| Transvaginal Botulinum Toxin A for Interstitial Cystitis / Bladder Pain Syndrome (NCT05485207) | Stanford University | 2022-04-04 |
| Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms (NCT05276466) | MicroGenDX | 2022-02-01 |
| Biopsychosocial and Conventional Approach in Bladder Pain Syndrome (NCT05155384) | Hacettepe University | 2021-11-12 |
| A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy (NCT05179460) | Janssen Research & Development, LLC | 2021-10-26 |
| Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (NCT04845217) | University of Louisville | 2021-09-15 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis (NCT05147779) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-09-12 |
| IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone (NCT04313972) | Endeavor Health | 2021-09-07 |
| Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome (NCT04734847) | University of Southern California | 2021-06-01 |
| Efficacy and Safety of Low Energy Shock Wave Plus BotulinumToxin A in Treating Patients With Interstitial Cystitis (NCT05275647) | Buddhist Tzu Chi General Hospital | 2021-05-18 |
| Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation (NCT04820855) | University of New Mexico | 2021-05-18 |
| Improving Female Sexual Wellness (NCT04824820) | Cedars-Sinai Medical Center | 2021-04-10 |
| Submucosal Intravesical Injection of Platelet-rich Plasma in the Treatment of Painful Bladder Syndrome (NCT06209008) | Ain Shams University | 2021-04-01 |
| PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome (NCT04540887) | Wake Forest University Health Sciences | 2021-02-24 |
| The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC) (NCT04349930) | University of New Mexico | 2021-01-01 |
| Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis (NCT04610359) | Asan Medical Center | 2020-10-20 |
| Low-dose Naltrexone for Bladder Pain Syndrome (NCT04450316) | Stanford University | 2020-10-08 |
| The Female Microbiome in Patients Undergoing Bladder Instillation Therapy (NCT05414305) | Walter Reed National Military Medical Center | 2020-10-01 |
| Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome (NCT04401176) | Walter Reed National Military Medical Center | 2020-09-15 |
| Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome (NCT04275297) | Vanderbilt University Medical Center | 2020-07-13 |
| Effects of Low-intensity Excoporeal Shock Wave Therapy (LiESWT) on Women With Pelvic Floor Dysfunction (NCT05337813) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2020-04-10 |
| PK and Safety of SI-722 in IC/BPS (NCT04208087) | Seikagaku Corporation | 2020-03-30 |
| Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments (NCT03844412) | Duke University | 2019-11-04 |
| Hypnosis for Bladder Pain Syndrome (NCT04010513) | University of Pennsylvania | 2019-10-03 |
| Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis (NCT04821882) | National Defense Medical Center, Taiwan | 2019-05-01 |
| Platelet Enriched Plasma for Treatment of Interstitial Cystitis (NCT04118946) | Mansoura University | 2019-03-20 |
| The Effects of Mindfulness-based Stress Reduction in Interstitial Cystitis Patients (NCT03722992) | TriHealth Inc. | 2019-03-07 |
| S1P1 Receptor Subtype (S1PR1) Axis in Patients With Interstitial Cystitis (IC) Pain (NCT03003845) | St. Louis University | 2019-02-26 |
| Clinical Trial Comparing Two Bladder Instillations for IC/BPS (NCT03463915) | Olivia Cardenas-Trowers, M.D. | 2019-01-25 |
| Effect of Interferential Electrical Stimulation on Pain Perception and Disability Level on Interstitial Cystitis (NCT03844581) | Cairo University | 2019-01-01 |
| Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study (NCT03931538) | Pathnostics | 2018-07-17 |
| Low Energy Shock Wave for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) (NCT03619486) | Chang Gung Memorial Hospital | 2018-07-04 |
| Adverse Childhood Experiences in Urogynecologic Patients (NCT03480477) | University of New Mexico | 2018-04-09 |
| Genetic and Histopathologic Characteristics of Interstitial Cystitis (NCT03523559) | Samsung Medical Center | 2018-03-31 |
| Physiotherapeutic Interventions Applied to the Bladder Pain Syndrome (NCT03755375) | University of Sao Paulo General Hospital | 2018-02-05 |
| A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis (NCT03282318) | Astellas Pharma Europe B.V. | 2017-09-28 |
| The Efficacy and Safety of Intravesical Hyaluronic Acid and Chondroitin Sulfate After Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients (NCT03463499) | Samsung Medical Center | 2017-09-22 |
| Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis (NCT03104361) | Buddhist Tzu Chi General Hospital | 2017-04-01 |
| Platelet Activating Factor Stability in Urine (NCT03103477) | St. Louis University | 2017-01-27 |
| Trans-MAPP II Study of Urologic Chronic Pelvin Pain (NCT02898220) | University of Pennsylvania | 2016-09-01 |
| Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome (NCT02858453) | Aquinox Pharmaceuticals (Canada) Inc. | 2016-07-01 |
| Observational Study of Hunner's Ulcer in Patient With Interstitial Cystitis/Bladder Pain Syndrome (NCT02150811) | Asan Medical Center | 2016-06-02 |
| HBOT for Patients With IC/FM (Interstitial Cystitis/Fibromyalgia) (NCT03693001) | University of South Florida | 2016-06-01 |
| Interstitial Cystitis and Urinary pH (NCT03024619) | St. Louis University | 2016-02-01 |
| Engage 24: Evaluation of the Safety and Effectiveness of URG101 in Subjects With Interstitial Cystitis/Bladder Pain Syndrome (NCT02591199) | Urigen | 2015-09-01 |
| Comparing the Effect of Fulguration Versus Fulguration and Hydrodistension in Interstitial Cystitis/Bladder Pain Syndrome (NCT03987594) | Yonsei University | 2015-08-01 |
| Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome (NCT01393223) | Lipella Pharmaceuticals, Inc. | 2015-07-21 |
| Trans-MAPP Symptom Patterns Study (SPS) (NCT02514265) | University of Pennsylvania | 2015-07-01 |
| Interstitial Cystitis (IC)-Like Findings With Hydrodistension (NCT02547298) | St. Louis University | 2015-06-01 |
| Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS (NCT02550561) | University of California, Irvine | 2015-06-01 |
| Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) (NCT02517996) | Johns Hopkins University | 2015-02-01 |
| Dietary Impact on Urinary pH in Women With Interstitial Cystitis (NCT03041194) | St. Louis University | 2015-01-01 |
| Intravesicular Onabotulinumtoxin A in Interstitial Cystitis (NCT02297100) | Wake Forest University Health Sciences | 2014-12-01 |
| Mindfulness-Based Therapy for Interstitial Cystitis/Bladder Pain Syndrome (NCT02457182) | University of New Mexico | 2014-11-01 |
| Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial (NCT02232282) | Loyola University | 2014-10-01 |
| Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis (NCT02247557) | Buddhist Tzu Chi General Hospital | 2014-09-01 |
| The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome (NCT01985880) | Asan Medical Center | 2013-11-19 |
| Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients (NCT01997983) | UroGen Pharma Ltd. | 2013-11-01 |
| Microbiome of Urologic Chronic Pelvic Pain Syndrome (NCT03027076) | Johns Hopkins University | 2013-11-01 |
| Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action (NCT01990898) | The Cleveland Clinic | 2013-11-01 |
| Efficacy and Safety of AQX-1125 in IC/BPS (NCT01882543) | Aquinox Pharmaceuticals (Canada) Inc. | 2013-06-01 |
| The Efficacy of Additional Intravesical Instillation of Hyaluronic Acid/Chondroitin Sulfate to Transurethral Resection of Bladder Ulcer in Patients With Interstitial Cystitis/Bladder Pain Syndrome. (NCT01813565) | Asan Medical Center | 2013-03-20 |
| Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (NCT01824303) | Allergan | 2013-03-01 |
| Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment (NCT01969773) | Buddhist Tzu Chi General Hospital | 2012-12-01 |
| Efficacy of Gralise® for Chronic Pelvic Pain (NCT01678911) | Shirley Ryan AbilityLab | 2012-08-01 |
| Therapeutic Effects of Endoscopic Ablation of Hunner Lesions in Interstitial Cystitis/ Bladder Pain Syndrome Patients (NCT03468530) | Samsung Medical Center | 2012-08-01 |
| Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) (NCT01731470) | Kenneth Peters, MD | 2012-07-01 |
| Microbiomes of Pelvic Pain (NCT01738464) | Northwestern University | 2012-06-01 |
| Bladder Thermal Distention for Patients With Interstitial Cystitis / Painful Bladder Syndrome (NCT01838486) | Assaf-Harofeh Medical Center | 2012-06-01 |
| Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain (NCT02000401) | Citrus Valley Medical Research, Inc. | 2012-05-01 |
| Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome (NCT01559961) | Trillium Therapeutics Inc. | 2012-03-01 |
| Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis (NCT01475253) | Allergan | 2011-11-01 |
| Bladder Capacity as Objective Measure of Intravesical Treatment of Newly Diagnosed IC (NCT05223244) | Endeavor Health | 2011-10-01 |
| Efficacy of Botulinum Toxin Type A in Patients With Bladder Pain Syndrome/Intersticial Cystitis and Hunners' Lesions (NCT01437579) | Moscow State University of Medicine and Dentistry | 2011-06-01 |
| Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia (NCT01378754) | Grace Shih, MD | 2011-06-01 |
| Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome (NCT01312259) | Pelvic and Sexual Health Institute | 2011-04-01 |
| Efficacy Study of Adalimumab to Treat Interstitial Cystitis (NCT01295814) | ICStudy, LLC | 2011-03-01 |
| Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis (NCT01479725) | Kenneth Peters, MD | 2011-03-01 |
| Female Chronic Pelvic Pain (NCT01255345) | Copenhagen University Hospital at Herlev | 2011-01-01 |
| Autonomic Response During Cystodistension in Patients Suspected of Having Interstitial Cystitis (NCT01301365) | Assaf-Harofeh Medical Center | 2010-11-01 |
| Intravesical Liposomes for Ulcerative Cystitis (NCT01083979) | Kenneth Peters, MD | 2010-08-01 |
| Safety Study of LiRIS in Interstitial Cystitis (IC) Patients (NCT01150565) | Allergan | 2010-07-01 |
| Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis (NCT00919802) | University of Alabama at Birmingham | 2010-06-01 |
| Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis (NCT01195116) | University of Rochester | 2010-05-01 |
| Assessing Chronic Pain Conditions in Patients (Pts) With and Without (w&wo) Interstitial Cystitis (NCT01138800) | Corewell Health East | 2010-05-01 |
| Prospective Trial Comparing Intravesical Chondroitin Sulphate 2% and DMSO in the Treatment of PBS/Interstitial Cystitis (NCT04268810) | National Multiple Sclerosis Center | 2010-03-01 |
| MAPP Investigation of Pelvic Floor-Brain Neurobiologic Axis in IC/IBS and IBS (NCT01280864) | Augusta University | 2010-03-01 |
| Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis (NCT01069263) | Assaf-Harofeh Medical Center | 2010-02-01 |
| Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis (NCT01098279) | University of Pennsylvania | 2009-12-01 |
| Osteopathic Manipulation for Female Interstitial Cystitis Patients With Sacroiliac Joint Dysfunction (NCT01311479) | Pelvic and Sexual Health Institute | 2009-11-01 |
| Urinary Biomarkers Characteristic to Interstitial Cystitis (NCT00971568) | Corewell Health East | 2009-09-01 |
| Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome (NCT00919113) | Watson Pharmaceuticals | 2009-07-01 |
| Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis (NCT00823030) | Northwell Health | 2009-01-01 |
| Correlating Ic/Pbs Symptoms With Urine Biomarkers (NCT00817388) | Corewell Health East | 2009-01-01 |
| Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis (NCT00873171) | CAMC Health System | 2009-01-01 |
| Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic Pain (NCT00554320) | Summa Health System | 2009-01-01 |
| An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis (NCT00739739) | Pfizer | 2008-08-01 |
| Physical Therapy in Women With Interstitial Cystitis (NCT00733603) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2008-06-01 |
| Relationship of Interstitial Cystitis to Vulvodynia (NCT00546858) | Corewell Health East | 2007-10-01 |
| A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome. (NCT00527917) | Watson Pharmaceuticals | 2007-09-01 |
| Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis (NCT00517868) | Urigen | 2007-08-28 |